Necsel Lasers for Medical Applications

L

asers offer advantages and design options that LEDs and lamps cannot match. Lumens are readily scalable, with different solutions depending on user requirements. New products with lasers are launching, providing key performance advantages to industry first-movers in photodynamic therapy, phototherapeutics, advanced diagnostic microscopy, surgical illumination, fluorescence excitation, Raman spectroscopy and more.

A variety of colors and narrow wavelengths can be generated with the NovaLum platform. Necsel has a key product strength with the ability to provide low cost compact laser modules that can be customized with up to 8 simultaneous laser wavelengths from violet to infra-red wavelengths in a single module, delivered into a single 400um 0.22NA fiber. Necsel also offers standard single wavelength laser modules with up to 10W with the same compact footprint.

The NovaTru Chroma and NovaTru Power product lines provide compact single box high power spectrum stabilized single-longitudinal-mode and power stabilized diode laser module solutions independent of the environmental temperature. These modules are offered in free space output as well as a variety of fiber pigtailed and direct fiber coupled configurations and contain integrated controllers with USB interfaces and I/O interfaces.

The Necsel Green Laser produces 3 W of power and from a package less than one cubic inch. This laser uses NECSEL patented technology to create wavelengths previously unavailable in the industry. Traditional 532nm applications as well as other green wavelengths as long as 555nm can be addressed with this time proven product with over 60,000 units currently in the field.

The Hyperion laser illumination system excels in demanding applications where high intensity light is required in the smallest of places. Designed with minimally invasive medical applications in mind, this product delivers cool, high-lux illumination that can be efficiently coupled into light channels that range from microns to millimeters. The power and versatility of this illuminator allow it to be coupled with fibers of the smallest size, enabling the use of much smaller endoscopes and video scopes. Additionally, Necsel is a medically certified ISO-13485 facility in order to help us serve our customers better and deliver solutions that they want in the medical and life sciences markets.

Necsel IP, Inc. develops and manufactures lasers and laser solutions for the projection, endoscopes, bio instrumentation, industrial and life sciences marketplaces. The company’s cost effect solutions provide these applications additional performance, such as brighter sources, higher contract ratios, longer lifetimes, and allows the creation of products that were never possible before. Necsel’s business model includes high-level customer interaction and co-development to rapidly advance its customer’s technology capability and product performance. The company is headquartered in Silicon Valley, CA with manufacturing facilities worldwide. To learn more about Necsel, visit www.necsel.com.

Ushio America, Inc. is a leading manufacturer of Specialty and General Illumination lighting solutions based in Cypress, California. Established in 1967 as a subsidiary of Ushio, Inc., in Tokyo, Japan, USHIO now carries over 2,500 General Lighting and Specialty products. These Lighting-Edge Technologies™ are provided to a variety of industries such as general illumination, audio-visual, photographic, stage, studio and television, semiconductor, printed circuit, video projection, cinema, UV curing, germicidal, horticulture, graphic arts, flashlight, scientific, medical, dental, ophthalmic, infra-red heating, and many others. For more information, visit www.USHIO.com.

We have two surgical blue lasers, one is 10-30W surgical blue laser for surgical treatment of bladder tumor, gastrointestinal diseases, and other superficial diseases, under endoscopic treatment. The other surgical blue laser is 160-180W high power version, specially designed for enlarged prostate (BPH). Hemoglobin (blood) has similar high absorption coefficient for 532nm green laser and 450nm blue laser. Due to the blue laser has much lower cost than surgical green lasers, our both blue lasers are targeted to replace the green lasers in the market.

The GLAUrious is clinically testing and validating the novel External Automatic Glaucoma Laser (EAGLE) device developed and patented by BELKIN Laser Ltd with the goal of providing accessible first-line treatment for glaucoma.

GLAUrious project aims to ease commercialization of the EAGLE device by securing clinical prototype validation, streamlining commercial production, optimizing component costs, disseminating to key opinion leaders and distributors, and refining commercial strategy.

The multidisciplinary GLAUrious Consortium is led by Queen's University Belfast (Northern Ireland, UK) consists of four additional partners- BELKIN Laser Ltd (Israel), Frankfurt Laser Company (Germany), MCI bvba (Belgium), Eye clinic University of Genova (Italy).

During the last year the advanced clinical prototype was produced and validated to meet the requirements of UK and Italian authorities’ towards prospective randomized clinical study initiation (trial registered at ISRCTN # 14033075).

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 720274.

Frankfurt Laser Company

An den 30 Morgen 13
D-61381 Friedrichsdorf
Germany

www.frlaserco.com

sales@frlaserco.com

Phone: +49 (0) 6172 27978-0